Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention Insights From the National Cardiovascular Data Registry

被引:62
|
作者
Valle, Javier A. [1 ]
McCoy, Lisa A. [2 ]
Maddox, Thomas M. [1 ,3 ]
Rumsfeld, John S. [1 ]
Ho, P. Michael [1 ,3 ]
Casserly, Ivan P. [4 ]
Nallamothu, Brahmajee K. [5 ]
Roe, Matthew T. [2 ,6 ]
Tsai, Thomas T. [1 ,7 ]
Messenger, John C. [1 ]
机构
[1] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO 80045 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Vet Affairs Eastern Colorado Hlth Care Syst, Div Cardiol, Denver, CO USA
[4] Mater Misericordiae Univ Hosp, Div Cardiol, Dublin, Ireland
[5] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
[6] Duke Univ, Div Cardiol, Durham, NC USA
[7] Kaiser Permanente Colorado, Inst Hlth Res, Dept Cardiol, Denver, CO USA
关键词
morbidity; mortality; outcome assessment (health care); percutaneous coronary intervention; renal insufficiency; CONTRAST-INDUCED NEPHROPATHY; ACUTE MYOCARDIAL-INFARCTION; CATHPCI REGISTRY; OUTCOMES; MORTALITY; RECOMMENDATIONS; ASSOCIATION; PREDICTORS; GUIDELINES; DISEASE;
D O I
10.1161/CIRCINTERVENTIONS.116.004439
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Acute kidney injury (AKI) remains a common complication after percutaneous coronary intervention (PCI) and is associated with adverse in-hospital patient outcomes. The incidence of adverse events after hospital discharge in patients having post-PCI AKI is poorly defined, and the relationship between AKI and outcomes after hospital discharge remains understudied. Methods and Results-Using the National Cardiovascular Data Registry CathPCI registry, we assessed the incidence of AKI among Medicare beneficiaries after PCI from 2004 to 2009 and subsequent post-discharge adverse events at 1 year. AKI was defined using Acute Kidney Injury Network (AKIN) criteria. Adverse events included death, myocardial infarction, bleeding, and recurrent kidney injury. Using Cox methods, we determined the relationship between in-hospital AKI and risk of post-discharge adverse events by AKIN stage. In a cohort of 453 475 elderly patients undergoing PCI, 39 850 developed AKI (8.8% overall; AKIN stage 1, 85.8%; AKIN 2/3, 14.2%). Compared with no AKI, in-hospital AKI was associated with higher post-discharge hazard of death, myocardial infarction, or bleeding (AKIN 1: hazard ratio [HR], 1.53; confidence interval [CI], 1.49-1.56 and AKIN 2/3: HR, 2.13; CI, 2.01-2.26), recurrent AKI (AKIN 1: HR, 1.70; CI, 1.64-1.76; AKIN 2/3: HR, 2.22; CI, 2.04-2.41), and AKI requiring dialysis (AKIN 1: HR, 2.59; CI, 2.29-2.92; AKIN 2/3: HR, 4.73; CI, 3.73-5.99). For each outcome, the highest incidence was within 30 days. Conclusions-Post-PCI AKI is associated with increased risk of death, myocardial infarction, bleeding, and recurrent renal injury after discharge. Post-PCI AKI should be recognized as a significant risk factor not only for in-hospital adverse events but also after hospital discharge.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] AD HOC PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: A REPORT FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY
    Faridi, Kamil
    Rymer, Jennifer
    Rao, Sunil V.
    Dai, Dadi
    Wojdyla, Daniel
    Wang, Tracy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 257 - 257
  • [32] Automating Risk Assessment of Acute Kidney Injury for Patients Undergoing Percutaneous Coronary Intervention
    Huang, Chenxi
    Murugiah, Karthik
    Annapureddy, Amarnath
    Schulz, Wade
    Masoudi, Frederick A.
    Rumsfeld, John
    Mortazavi, Bobak
    Krumholz, Harlan M.
    CIRCULATION, 2021, 144
  • [33] The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
    Chiang, Cheng-Hung
    Hung, Wan-Ting
    Liu, En-Shao
    Yang, Tse-Hsuan
    Cheng, Chin-Chang
    Huang, Wei-Chun
    Mar, Guang-Yuan
    Kuo, Feng-Yu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [34] TRENDS AND PREDICTORS OF LENGTH OF STAY AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION: A REPORT FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY
    Chin, Chee Tang
    Wang, Tracy Y.
    Dai, David
    Roe, Matthew T.
    Mehta, Rajendra H.
    Rumsfeld, John S.
    Anderson, Vernon
    Weintraub, William S.
    Messenger, John C.
    Kutcher, Michael A.
    Brindis, Ralph G.
    Peterson, Eric D.
    Harrington, Robert A.
    Rao, Sunil V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [35] Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Chen, Zhihao
    Jiang, Chaohui
    Qu, Huimin
    Liang, Shuang
    Yang, Jian
    Wu, Hui
    He, Chao
    Wang, Xinan
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (06) : 1375 - 1380
  • [36] Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention The PARIS Registry
    Sorrentino, Sabato
    Sartori, Samantha
    Baber, Usman
    Claessen, Bimmer E.
    Giustino, Gennaro
    Chandrasekhar, Jaya
    Chandiramani, Rishi
    Cohen, David J.
    Henry, Timothy D.
    Guedeney, Paul
    Ariti, Cono
    Dangas, George
    Gibson, C. Michael
    Krucoff, Mitchell W.
    Moliterno, David J.
    Colombo, Antonio
    Vogel, Birgit
    Chieffo, Alaide
    Kini, Annapoorna S.
    Witzenbichler, Bernhard
    Weisz, Giora
    Steg, Philippe Gabriel
    Pocock, Stuart
    Urban, Philip
    Mehran, Roxana
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : E008226
  • [37] Increased Adverse Events After Percutaneous Coronary Intervention in Patients With COPD
    Reed, Robert M.
    Scharf, Steven
    CHEST, 2012, 141 (03) : 828 - 829
  • [38] Comparison of Machine Learning Methods With National Cardiovascular Data Registry Models for Prediction of Risk of Bleeding After Percutaneous Coronary Intervention
    Mortazavi, Bobak J.
    Bucholz, Emily M.
    Desai, Nihar R.
    Huang, Chenxi
    Curtis, Jeptha P.
    Masoudi, Frederick A.
    Shaw, Richard E.
    Negahban, Sahand N.
    Krumholz, Harlan M.
    JAMA NETWORK OPEN, 2019, 2 (07)
  • [39] Patient Selection for Diagnostic Coronary Angiography and Hospital-Level Percutaneous Coronary Intervention Appropriateness Insights From the National Cardiovascular Data Registry
    Bradley, Steven M.
    Spertus, John A.
    Kennedy, Kevin F.
    Nallamothu, Brahmajee K.
    Chan, Paul S.
    Patel, Manesh R.
    Bryson, Chris L.
    Malenka, David J.
    Rumsfeld, John S.
    JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1630 - 1639
  • [40] Standard modifiable cardiovascular risk factors in patients with acute coronary syndrome: A report from multicenter percutaneous coronary intervention registry
    Iwata, Juri
    Inohara, Taku
    Shiraishi, Yasuyuki
    Nakamaru, Ryo
    Niimi, Nozomi
    Ueda, Ikuko
    Suzuki, Masahiro
    Noma, Shigetaka
    Numasawa, Yohei
    Fukuda, Keiichi
    Kohsaka, Shun
    JOURNAL OF CARDIOLOGY, 2023, 81 (06) : 571 - 576